Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly
emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, …

Objective Currently, there are no definitive data on the relationship between low levels of
vitamin D in the blood and a more severe disease course, in terms of the need for hospital …

There is limited information describing features and outcomes of patients requiring
hospitalization for COVID19 disease and still no treatments have clearly demonstrated efficacy. …

Non-invasive respiratory support (NIRS) in adult, pediatric, and neonatal patients with acute
respiratory failure (ARF) comprises two treatment modalities, non-invasive mechanical …

We retrospectively evaluated 2879 hospitalized COVID-19 patients from four hospitals to
evaluate the ability of demographic data, medical history, and on-admission laboratory …

Introduction Tocilizumab is an interleukin 6 receptor antagonist which has been used for the
treatment of severe SARS-CoV-2 pneumonia (SSP), aiming to ameliorate the cytokine …

Introduction Mortality risk prediction for Intermediate Respiratory Care Unit's (IRCU) patients
can facilitate optimal treatment in high-risk patients. While Intensive Care Units (ICUs) have …

Background Quantification of intrinsic PEEP (PEEPi) has important implications for patients
subjected to invasive mechanical ventilation. A new non-invasive breath-by-breath method (…

Introduction Historically, it has been assumed that Intermediate Respiratory Care Units (IRCU)
were efficient, because they saved costs by reducing the number of admissions to …

La enfermedad por coronavirus 2019 (COVID-19) es una infección del tracto respiratorio
causada por un nuevo coronavirus emergente que se reconoció por primera vez en Wuhan, …